Characterization of Human γδ T Lymphocytes Infiltrating Primary Malignant Melanomas

被引:107
作者
Cordova, Adriana [2 ]
Toia, Francesca [2 ]
La Mendola, Carmela [1 ]
Orlando, Valentina [1 ]
Meraviglia, Serena [1 ]
Rinaldi, Gaetana [2 ]
Todaro, Matilde [2 ]
Cicero, Giuseppe [2 ]
Zichichi, Leonardo [3 ]
Donni, Paolo Li
Caccamo, Nadia [1 ]
Stassi, Giorgio [2 ]
Dieli, Francesco [1 ]
Moschella, Francesco [2 ]
机构
[1] Univ Palermo, Dipartimento Biopatol & Biotecnol Med & Forensi, Palermo, Italy
[2] Univ Palermo, Dipartimento Discipline Chirurg & Oncol, Palermo, Italy
[3] Azienda Osped S Antonio Abate, Unita Operativa Dermatol, Trapani, Italy
关键词
OVERCOMING IMMUNOLOGICAL-TOLERANCE; PHASE-I; METASTATIC MELANOMA; MEVALONATE PATHWAY; TARGETING CTLA-4; CELL-THERAPY; TUMOR-CELLS; LYMPH-NODES; IMMUNOTHERAPY; CANCER;
D O I
10.1371/journal.pone.0049878
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
T lymphocytes are often induced naturally in melanoma patients and infiltrate tumors. Given that gamma delta T cells mediate antigen-specific killing of tumor cells, we studied the representation and the in vitro cytokine production and cytotoxic activity of tumor infiltrating gamma delta T cells from 74 patients with primary melanoma. We found that gamma delta T cells represent the major lymphocyte population infiltrating melanoma, and both V delta 1(+) and V delta 2(+) cells are involved. The majority of melanoma-infiltrating gamma delta cells showed effector memory and terminally-differentiated phenotypes and, accordingly, polyclonal gamma delta T cell lines obtained from tumor-infiltrating immune cells produced IFN-gamma and TNF-alpha and were capable of killing melanoma cell lines in vitro. The cytotoxic capability of V delta 2 cell lines was further improved by pre-treatment of tumor target cells with zoledronate. Moreover, higher rate of gamma delta T cells isolation and percentages of V delta 2 cells correlate with early stage of development of melanoma and absence of metastasis. Altogether, our results suggest that a natural immune response mediated by gamma delta T lymphocytes may contribute to the immunosurveillance of melanoma.
引用
收藏
页数:9
相关论文
共 55 条
[31]   Bisphosphonates target multiple sites in both cis- and trans-prenyltransferases [J].
Guo, Rey-Ting ;
Cao, Rong ;
Liang, Po-Huang ;
Ko, Tzu-Ping ;
Chang, Tao-Hsin ;
Hudock, Michael P. ;
Jeng, Wen-Yih ;
Chen, Cammy K. -M. ;
Zhang, Yonghui ;
Song, Yongcheng ;
Kuo, Chih-Jung ;
Yin, Fenglin ;
Oldfield, Eric ;
Wang, Andrew H. -J. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (24) :10022-10027
[32]   γδ T Cells and the Lymphoid Stress-Surveillance Response [J].
Hayday, Adrian C. .
IMMUNITY, 2009, 31 (02) :184-196
[33]   Improved Survival with Ipilimumab in Patients with Metastatic Melanoma [J].
Hodi, F. Stephen ;
O'Day, Steven J. ;
McDermott, David F. ;
Weber, Robert W. ;
Sosman, Jeffrey A. ;
Haanen, John B. ;
Gonzalez, Rene ;
Robert, Caroline ;
Schadendorf, Dirk ;
Hassel, Jessica C. ;
Akerley, Wallace ;
van den Eertwegh, Alfons J. M. ;
Lutzky, Jose ;
Lorigan, Paul ;
Vaubel, Julia M. ;
Linette, Gerald P. ;
Hogg, David ;
Ottensmeier, Christian H. ;
Lebbe, Celeste ;
Peschel, Christian ;
Quirt, Ian ;
Clark, Joseph I. ;
Wolchok, Jedd D. ;
Weber, Jeffrey S. ;
Tian, Jason ;
Yellin, Michael J. ;
Nichol, Geoffrey M. ;
Hoos, Axel ;
Urba, Walter J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (08) :711-723
[34]   Questionable relevance of γδ T lymphocytes in renal cell carcinoma [J].
Inman, Brant A. ;
Frigola, Xavier ;
Harris, Kimberley J. ;
Kuntz, Susan M. ;
Lohse, Christine M. ;
Leibovich, Bradley C. ;
Kwon, Eugene D. .
JOURNAL OF IMMUNOLOGY, 2008, 180 (05) :3578-3584
[35]   Spontaneous regression of metastases from melanoma: review of the literature [J].
Kalialis, Louise Vennegaard ;
Drzewiecki, Krzysztof T. ;
Klyver, Helle .
MELANOMA RESEARCH, 2009, 19 (05) :275-282
[36]   Dysregulation of the host mevalonate pathway during early bacterial infection activates human TCR γδ cells [J].
Kistowska, Magdalena ;
Rossy, Emmanuel ;
Sansano, Sebastiano ;
Gober, Hans-Juergen ;
Landmann, Regine ;
Mori, Lucia ;
De Libero, Gennaro .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2008, 38 (08) :2200-2209
[37]   Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study [J].
Kobayashi, Hirohito ;
Tanaka, Yoshimasa ;
Yagi, Junji ;
Osaka, Yukinari ;
Nakazawa, Hayakazu ;
Uchiyama, Takehiko ;
Minato, Nagahiro ;
Toma, Hiroshi .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2007, 56 (04) :469-476
[38]   Identification of a Novel Proinflammatory Human Skin-Homing Vγ9Vδ2 T Cell Subset with a Potential Role in Psoriasis [J].
Laggner, Ute ;
Di Meglio, Paola ;
Perera, Gayathri K. ;
Hundhausen, Christian ;
Lacy, Katie E. ;
Ali, Niwa ;
Smith, Catherine H. ;
Hayday, Adrian C. ;
Nickoloff, Brian J. ;
Nestle, Frank O. .
JOURNAL OF IMMUNOLOGY, 2011, 187 (05) :2783-2793
[39]   Reduced Expression of the Mevalonate Pathway Enzyme Farnesyl Pyrophosphate Synthase Unveils Recognition of Tumor Cells by Vγ9Vδ2 T Cells [J].
Li, Jianqiang ;
Herold, Marco J. ;
Kimmel, Brigitte ;
Mueller, Ingrid ;
Rincon-Orozco, Bladimiro ;
Kunzmann, Volker ;
Herrmann, Thomas .
JOURNAL OF IMMUNOLOGY, 2009, 182 (12) :8118-8124
[40]   In vivo manipulation of Vγ9Vδ2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients [J].
Meraviglia, S. ;
Eberl, M. ;
Vermijlen, D. ;
Todaro, M. ;
Buccheri, S. ;
Cicero, G. ;
La Mendola, C. ;
Guggino, G. ;
D'Asaro, M. ;
Orlando, V. ;
Scarpa, F. ;
Roberts, A. ;
Caccamo, N. ;
Stassi, G. ;
Dieli, F. ;
Hayday, A. C. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2010, 161 (02) :290-297